PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $356,951 | -2.8% | 115,518 | +41.6% | 0.00% | – |
| Q2 2023 | $367,178 | +204.3% | 81,595 | +285.5% | 0.00% | – |
| Q1 2023 | $120,652 | -5.6% | 21,167 | 0.0% | 0.00% | – |
| Q4 2022 | $127,849 | -8.7% | 21,167 | 0.0% | 0.00% | – |
| Q3 2022 | $140,000 | +27.3% | 21,167 | 0.0% | 0.00% | – |
| Q2 2022 | $110,000 | -84.4% | 21,167 | -79.2% | 0.00% | – |
| Q1 2022 | $703,000 | -47.3% | 101,906 | -4.9% | 0.00% | – |
| Q4 2021 | $1,335,000 | -59.9% | 107,184 | +0.7% | 0.00% | -100.0% |
| Q3 2021 | $3,326,000 | -2.1% | 106,425 | -10.3% | 0.00% | 0.0% |
| Q2 2021 | $3,398,000 | -32.1% | 118,677 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $5,005,000 | -39.2% | 115,499 | +0.4% | 0.00% | -50.0% |
| Q4 2020 | $8,229,000 | – | 115,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
| Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
| Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
| HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
| Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
| Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
| FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
| Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
| FMR LLC | 7,055,666 | $220,489,000 | 0.02% |